BriaCell Therapeutics (BCTXF) News Today → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free BCTXF Stock Alerts $2.24 +0.05 (+2.28%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartHeadlinesStock AnalysisChartHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBriaCell Therapeutics (OTCMKTS:BCTXF) Stock Price Down 5.6%americanbankingnews.com - April 25 at 1:48 AMBriaCell Therapeutics Corp Ordinary Shares - New BCTmorningstar.com - April 21 at 8:25 AMBriaCell’s Shareholders Approve Directors and Auditorsmsn.com - February 2 at 12:54 AMBriaCell Therapeutics Corp.: BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with "Eye-Bulging" Metastatic Breast Cancerfinanznachrichten.de - January 4 at 1:13 PMMiNA Therapeutics Highlights Preclinical Research on RNA Activation (RNAa) Therapeutics Presented at the Oligonucleotide Therapeutics Society (OTS) Annual Meetingbusinesswire.com - November 15 at 11:23 PMBriaCell Forms Medical Advisory Board of Distinguished Breast Cancer Specialists to Advance its Lead Oncology Candidatefinance.yahoo.com - October 25 at 10:25 AMOctober is Breast Cancer Awareness Month – BriaCell is Leading the Fight with its Innovative Technologyfinance.yahoo.com - October 20 at 10:06 AMClosing Bell: Briacell Therapeutics Corp flat on Monday (BCT)theglobeandmail.com - September 26 at 7:54 AMBriaCell Therapeutics: Poised To Move To Advanced Trials, But An Unconvincing Thesismsn.com - September 10 at 2:40 AMBriaCell Reports Benchmark-Beating Patient Survival and Clinical Benefit in Advanced Metastatic Breast Cancerfinance.yahoo.com - September 8 at 8:20 AMBriaCell Therapeutics Corp. Announces Voting Results From Special Meetingfinance.yahoo.com - August 18 at 1:06 PMBriaCell receives NCI grant for cancer platform developmentmsn.com - August 17 at 10:03 AMBriaCell Therapeutics: Stocks Undervalued by Analyst Consensus on TSX (BCT)theglobeandmail.com - July 22 at 10:44 PMBriaCell Therapeutics (BCT) Gets a Buy Rating from H.C. Wainwrightmarkets.businessinsider.com - June 28 at 8:54 AMBriaCell Therapeutics in Definitive Agreement to Spin Off Certain Assetsmarketwatch.com - May 25 at 12:38 PMBriaCell to spin out BriaPro Therapeuticsmsn.com - May 25 at 12:38 PMBriaCell Therapeutics: Top 25 Performing Stocks Year-to-Date on Toronto Stock Exchange (BCT)theglobeandmail.com - April 27 at 7:59 AMClosing Bell: Briacell Therapeutics Corp down on Thursday (BCT)theglobeandmail.com - April 7 at 9:34 PMToronto Stocks Advance as Banking Sector Sentiment Improves; BriaCell Slides on Spinoff Plansmorningstar.com - April 1 at 9:18 PMBriaCell Therapeutics to Spin Off Certain Assetsmarketwatch.com - March 30 at 1:57 PMBriaCell Sees Positive Survival Data in Ongoing Trialmarketwatch.com - February 23 at 10:26 AMBriaCell Reports Positive Survival Data in Advanced Metastatic Breast Cancerfinance.yahoo.com - February 23 at 10:26 AMBriaCell to Investigate Potential Stock Manipulationmarketwatch.com - January 23 at 10:05 AMBriaCell Announces New Patent Issuance, Bria-OTS(TM) IND Timing Guidance, and Additional Clinical Sites to Boost Enrolmentstockhouse.com - January 12 at 1:10 PMBriaCell to get US, Australian patent linked to personalized cancer immunotherapymsn.com - January 10 at 1:02 PMBriaCell signs exclusive licensing deal with UMBC for cancer treatment candidatebizjournals.com - August 5 at 3:32 PMBriaCell Therapeutics Corp. (TSE:BCT) insider upped their holding earlier this yearfinance.yahoo.com - July 21 at 9:20 AMBriaCell Partners with Waisman Biomanufacturing to Manufacture and Supply Prostate Cancer Immunotherapynz.finance.yahoo.com - July 5 at 9:08 AMWe're Hopeful That BriaCell Therapeutics (TSE:BCT) Will Use Its Cash Wiselynz.finance.yahoo.com - May 6 at 5:33 PMWhy BriaCell Therapeutics Stock Is Surging Todaymsn.com - April 13 at 2:42 PMBriaCell gains on FDA fast track nod for its targeted breast cancer immunotherapy Bria-IMTseekingalpha.com - April 13 at 9:41 AMWhy BriaCell Therapeutics Is Rising In Pre-market?nasdaq.com - April 13 at 9:41 AMBriaCell Adds Two Clinical Trial Sites to Accelerate Patient Enrollmentfinance.yahoo.com - February 28 at 9:46 AMBriaCell Therapeutics Corp. Announces Results of 2022 Annual and Special Meeting of Shareholdersnz.finance.yahoo.com - January 19 at 6:22 PMBriaCell Moves Forward to Initiate Phase I/IIa Clinical Study for BriaVax(TM) in Advanced Breast Cancerfinance.yahoo.com - October 26 at 4:34 AMBriaCell Therapeutics CEO Emphasizes Recent Key Developments in Audio Interview with SmallCapVoice.comfinance.yahoo.com - September 23 at 8:40 AMBriaCell Announces TSXV Acceptance of Normal Course Issuer Bidfinance.yahoo.com - September 22 at 9:39 AMBriaCell Announces Securities Buyback to Purchase up to 10% of Common Shares and up to 10% of Listed Warrantsfinance.yahoo.com - September 9 at 3:54 PMBriaCell Therapeutics Appoints Marc Lustig to its Board of Directorsfinance.yahoo.com - September 1 at 5:00 PMBriaCell and ImaginAb Announce Collaboration to Evaluate Immunotherapy Imaging Technology in ...apnews.com - August 20 at 4:46 PMBRIEF-Briacell Therapeutics Says Will Voluntarily Delist Its Common Shares From Trading On Frankfurt Stock Exchange Effective August 19msn.com - August 17 at 3:41 PML5 Capital Announces Acquisition of Common Shares of BriaCell Therapeutics Corp.finance.yahoo.com - August 6 at 11:25 AM Get BriaCell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCTXF and its competitors with MarketBeat's FREE daily newsletter. Email Address Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> BCTXF Media Mentions By Week BCTXF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BCTXF News Sentiment▼0.300.41▲Average Medical News Sentiment BCTXF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BCTXF Articles This Week▼20▲BCTXF Articles Average Week Get BriaCell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCTXF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: GRI Bio News Today Panbela Therapeutics News Today NeuBase Therapeutics News Today 180 Life Sciences News Today PainReform News Today InMed Pharmaceuticals News Today Galmed Pharmaceuticals News Today Qualigen Therapeutics News Today Clearmind Medicine News Today Comera Life Sciences News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:BCTXF) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BriaCell Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
